COMMENTRussia’s focus on domestic pharma production could shield it from sanctionsHeart failure: charting the clinical trial landscape in the past decadeDelayed EMA approval: improved safety or lack of access to therapeutics?Non-stop investment from CMOs and US Government into continuous manufacturingDrug DevelopmentA disappointing June for Alzheimer’s disease signals setbacks for several productsSeveral companies have announced poor results from clinical trials for Alzheimer’s disease therapies this month.insightEurope reports the highest prevalence of chronic coughcommentCould vaccine hesitancy impact hearing disorders?Russia’s focus on domestic pharma production could shield it from sanctionsHeart failure: charting the clinical trial landscape in the past decadeDelayed EMA approval: improved safety or lack of access to therapeutics?Non-stop investment from CMOs and US Government into continuous manufacturing02/23/2024 23:35:17
Russia’s focus on domestic pharma production could shield it from sanctions
Heart failure: charting the clinical trial landscape in the past decade
Delayed EMA approval: improved safety or lack of access to therapeutics?
Non-stop investment from CMOs and US Government into continuous manufacturing